Purpose To describe the safety and effectiveness of using autologous serum-based eye
drops for the treatment of severe dry eye and persistent corneal epithelial defect. Methods …

Autologous serum drops have been reported to be beneficial in keratoconjunctivitis sicca
(KCS) and persistent epithelial defects (PED). The authors conducted a clinical pilot study to …

Background Serum eyedrops have been successfully used in the treatment of severe dry
eye, persistent epithelial defects and other severe ocular surface disorders. A number of …

Objective To review the use and preparation of serum drops for the treatment of ocular
surface disease in Canada and to assess the need for an improved access to this therapy …

Tears are the essential component to the maintenance of healthy ocular surface epithelium.
When tears are depleted, various pathological reactions occur, such as squamous …

Abstract Purpose Serum eye drops (SEDs) are used to treat a variety of ocular surface
defects. Serum eye drops (SEDs) are normally produced from the patient's blood. However …

Purpose The study aims to describe an intact cohort with mixed ocular surface disease
(OSD) treated with autologous serum (AS) eye drops in a tertiary eye center. Patients and …

BACKGROUND/AIMS Autologous serum drops have been reported to be beneficial in
keratoconjunctivitis sicca (KCS) and persistent epithelial defects (PED). A clinical pilot study …

The majority of patients with ocular surface disease respond to conventional treatment
aimed at optimising the ocular surface environment. Despite maximal conventional therapy …

Aim: To assess microbial contamination of 20% autologous serum (AS) eye drops used in a
hospital inpatient setting. Method: 14 patients received autologous serum drops from 4 to 14 …